Interferon-? ELISPOT as a biomarker of treatment efficacy in latent tuberculosis infection: a clinical trial. (2013)

First Author: Adetifa IM
Attributed to:  Vaccines & Immunity Research MRC Unit, The Gambia funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1164/rccm.201208-1352OC

PubMed Identifier: 23220919

Publication URI: http://europepmc.org/abstract/MED/23220919

Type: Journal Article/Review

Volume: 187

Parent Publication: American journal of respiratory and critical care medicine

Issue: 4

ISSN: 1073-449X